Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 553, pseudogene (RN7SL553P)

Target
RN7SL553P
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

RNA, 7SL, cytoplasmic 553, pseudogene (RN7SL553P) is a **pseudogene**, meaning it is a genomic DNA segment that closely resembles a functional gene but is generally considered nonfunctional and does not encode a functional product[1][6][7][8]. Specifically, RN7SL553P is classified as a 7SL RNA-derived pseudogene; the authentic 7SL RNA is an essential component of the **signal recognition particle (SRP)** ribonucleoprotein complex, which mediates the targeting of secretory and membrane proteins to the endoplasmic reticulum in eukaryotic cells[5]. However, pseudogenes like RN7SL553P do not produce functional RNA or protein and are not considered druggable or therapeutic targets; they lack roles as receptors, enzymes, transporters, or related classes relevant for drug targeting[1][6][7]. Their biological functions in physiology or disease are generally absent, although emerging evidence suggests some pseudogenes could potentially have regulatory roles, such as acting as competing endogenous RNAs or miRNA sponges in other contexts[4]; no specific evidence associates RN7SL553P with such activity. RN7SL553P has no known disease association, interacting drugs, mechanism-of-action, biomarker utility, or notable safety concern. Since it lacks therapeutic target credentials and functional annotation, RN7SL553P is not considered a druggable target and the query asking for receptor or target details is **incorrect** in context[1][8].

Other names
RN7SL553P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 553, pseudogene (RN7SL553P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 553, pseudogene (RN7SL553P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call